NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
DCM Nouvelle Q3 Results: Revenue up 14.5% QoQ, Net Loss of ₹33.9 Cr due to Subsidiary Impairment
DCM Nouvelle reported a revenue of ₹269.21 crore for Q3 FY26, a 14.5% increase sequentially from ₹235.11 crore in Q2. Despite the revenue growth and improved operational profit before tax of ₹4.58 crore, the company posted a net loss of ₹33.90 crore. This loss was primarily driven by a significant non-cash exceptional item of ₹35.61 crore representing an impairment provision for its subsidiary, DCM Nouvelle Specialty Chemicals Limited. Additionally, the company recognized a ₹1.86 crore charge related to the implementation of new labor codes.
முக்கிய அம்சங்கள்
Revenue from operations grew 14.5% QoQ to ₹269.21 crore, though 9M revenue is down 3.8% YoY.Reported a net loss of ₹33.90 crore in Q3 FY26 against a profit of ₹2.21 crore in Q3 FY25.Recognized a one-time impairment charge of ₹35.61 crore for its specialty chemicals subsidiary based on value-in-use assessment.Operational profit before exceptional items improved to ₹4.58 crore from ₹1.88 crore in the preceding quarter.Exceptional items also include a ₹1.86 crore statutory impact from the notification of new Labour Codes.
👀 கவனிக்க வேண்டியவை
Investors should exercise caution as the large impairment suggests the specialty chemicals venture is underperforming expectations. While the core textile business shows signs of sequential recovery, the overall financial health is currently weighed down by subsidiary-level write-downs.
DCM Shriram Industries Sets Cost Apportionment Ratio for Demerged Entities
DCM Shriram Industries has announced the cost of acquisition apportionment for its shareholders following the demerger of its Chemical and Rayon undertakings. For every 1 equity share held in the parent company, shareholders have been allotted 1 share each in DCM Shriram Fine Chemicals Limited and DCM Shriram International Limited. The cost of acquisition for the original shares will now be split among the three entities based on specific percentages for tax purposes. This update follows the scheme of arrangement that became effective on December 17, 2025.
முக்கிய அம்சங்கள்
Cost of acquisition for DCM Shriram Industries Limited (Parent) is set at 42.66%Cost of acquisition for DCM Shriram Fine Chemicals Limited is set at 25.22%Cost of acquisition for DCM Shriram International Limited is set at 32.12%Share entitlement ratio is 1:1:1 for the parent and the two resulting companiesThe apportionment is based on the net book value of assets transferred as of the demerger date
👀 கவனிக்க வேண்டியவை
Shareholders should use these ratios to adjust their purchase price records for tax compliance and capital gains calculations. No immediate action is required regarding the holding of the shares themselves.
DCM Shriram Q3 FY26 Revenue Up 13% to ₹3,811 Cr; Announces 180% Interim Dividend
DCM Shriram reported a 13% YoY increase in Q3 FY26 revenue to ₹3,811 crore, driven by strong performance in Chemicals and Sugar segments. PBDIT grew 4% to ₹560 crore, while PAT was impacted by a ₹55 crore exceptional item related to the implementation of new labor codes. The Chemicals segment saw 30% revenue growth despite lower ECU prices, and the Sugar segment benefited from higher volumes and a ₹36 crore provision reversal. The board declared an interim dividend of 180%, reflecting steady cash flow despite ongoing capital expenditure.
முக்கிய அம்சங்கள்
Q3 FY26 Revenue rose 13% YoY to ₹3,811 crore, while PBDIT increased 4% to ₹560 crore.Chemicals revenue jumped 30% YoY, supported by new projects like Hydrogen Peroxide and Epoxy, despite a 4% drop in ECUs.Sugar & Ethanol PBDIT surged to ₹204 crore from ₹112 crore last year, aided by a ₹36 crore provision reversal.Net debt stood at ₹1,084 crore as of Dec 31, 2025, down from ₹1,395 crore in March 2025.Board declared an interim dividend of 180% amounting to a total payout of ₹56.14 crore.
👀 கவனிக்க வேண்டியவை
Investors should monitor the stabilization of the newly commissioned Epichlorohydrin (ECH) plant and the upcoming aluminum extrusion project at Kota. The company's diversified portfolio and consistent dividend payouts make it a resilient pick in the industrial and agri-input space.
DCM Shriram Q3 FY26: Revenue Up 13% to ₹3,811 Cr; PAT Dips 19% on Exceptional Charge
DCM Shriram reported a resilient Q3 FY26 with consolidated net revenue rising 13% YoY to ₹3,811 crore, driven by a 30% growth in the Chemicals segment and a 28% jump in Fenesta. While PBDIT grew 4% to ₹560 crore, PAT declined 19% YoY to ₹213 crore due to a one-time exceptional charge of ₹55 crore related to new labor codes. The company is successfully diversifying into downstream chemicals like Epichlorohydrin and Epoxy resins, which are seeing good market traction. A dividend of ₹56.14 crores was also announced during the quarter.
முக்கிய அம்சங்கள்
Consolidated Net Revenue grew 13% YoY to ₹3,811 crore, supported by volume-led growth in Chemicals.PAT decreased by 19% YoY to ₹213 crore, impacted by a ₹55 crore one-time labor code provision.Chemicals revenue surged 30% YoY following the commissioning of new projects and the Epoxy plant acquisition.Shriram Farm Solutions achieved its highest-ever quarterly sales in research wheat seed, contributing to 7% segment growth.Fenesta Building Systems continued its strong momentum with a 28% YoY revenue increase.
👀 கவனிக்க வேண்டியவை
Investors should focus on the successful ramp-up of new chemical capacities and the potential margin improvement from anti-dumping duties on Epoxy resins. The company's diversified model provides stability, though sugar sector cost pressures remain a point to watch.
DCM Shriram Industries Proposes Appointment of 4 Directors; E-voting Starts Jan 26
DCM Shriram Industries has issued a postal ballot notice to seek shareholder approval for four key board appointments. This includes two Independent Directors, Mr. Anurag Surana and Mr. Sidharth Prasad, for five-year terms ending in December 2030. Additionally, the company is seeking approval for Mr. Uday Shriram as Deputy Managing Director and Mr. Rohan Shriram as Whole Time Director, both for five-year terms starting December 23, 2025. The e-voting process is scheduled to run from January 26 to February 24, 2026.
முக்கிய அம்சங்கள்
Appointment of two Independent Directors for 5-year terms ending December 9, 2030.Mr. Uday Shriram and Mr. Rohan Shriram proposed for executive roles for 5-year terms from Dec 23, 2025.Remote e-voting period scheduled from Jan 26, 2026, to Feb 24, 2026.All four resolutions are proposed as Special Resolutions requiring 75% majority approval.The cut-off date for determining shareholder voting eligibility was January 19, 2026.
👀 கவனிக்க வேண்டியவை
Investors should review the professional backgrounds of the proposed directors to ensure leadership alignment with the company's growth strategy. No immediate portfolio action is required as these are standard governance procedures.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
DCM Shriram Q3 PAT Falls 19% to Rs 201 Cr; Declares Rs 3.60 Interim Dividend
DCM Shriram reported a 12.6% YoY increase in standalone revenue to Rs 3,858 crore for Q3 FY26, while Profit After Tax (PAT) declined 19% to Rs 201 crore. The earnings were significantly impacted by a one-time exceptional provision of Rs 55 crore for the new statutory Labour Codes. The Board declared a second interim dividend of Rs 3.60 per share, with the record date set for January 24, 2026. For the nine-month period, the company maintains a healthy growth with PAT at Rs 466.56 crore versus Rs 391.84 crore last year.
முக்கிய அம்சங்கள்
Standalone Revenue from operations rose 12.6% YoY to Rs 3,858.02 crore in Q3 FY26.Net Profit (PAT) decreased 19.1% YoY to Rs 201.36 crore due to a Rs 55 crore exceptional charge.Declared a second interim dividend of Rs 3.60 per share (180% of face value).EBIDTA grew 4.5% YoY to Rs 540.03 crore, reflecting stable operational performance.The record date for the interim dividend is fixed as January 24, 2026.
👀 கவனிக்க வேண்டியவை
The stock remains a steady dividend payer, but the exceptional hit to margins this quarter suggests a neutral outlook. Long-term investors should watch for recovery in seasonal segments and clarity on labour code liabilities.
DCM Shriram Industries Completes Share Allotment for Demerger; Effective Date Dec 17, 2025
DCM Shriram Industries has finalized the allotment and credit of equity shares for its two resulting companies, DCM Shriram Fine Chemicals and DCM Shriram International, under a composite scheme of arrangement. The effective date of the scheme is confirmed as December 17, 2025, following the filing of NCLT orders. As a result, these entities have ceased to be subsidiaries and are now independent companies. Both resulting companies are currently seeking listing and trading permissions from the BSE and NSE to provide liquidity to shareholders.
முக்கிய அம்சங்கள்
Effective date of the demerger scheme confirmed as December 17, 2025.Shares of DCM Shriram Fine Chemicals and DCM Shriram International credited to eligible shareholders.Resulting companies have ceased to be wholly-owned subsidiaries of DCM Shriram Industries.Listing applications for the new entities are being processed with BSE and NSE.Pre-scheme share capital of the resulting companies held by the parent has been cancelled.
👀 கவனிக்க வேண்டியவை
Shareholders should verify the credit of new shares in their demat accounts and monitor upcoming exchange notifications for the listing dates of the two new entities.
DCM Shriram Board to Meet Jan 20 for Q3 Results and 2nd Interim Dividend
DCM Shriram Limited has scheduled a board meeting on January 20, 2026, to approve the unaudited financial results for the quarter and nine months ended December 31, 2025. The board will also consider the declaration of a second interim dividend for the financial year 2025-26. If approved, the company has already fixed January 24, 2026, as the record date for determining shareholder eligibility. The trading window for the company's equity shares is currently closed and will remain so until January 22, 2026.
முக்கிய அம்சங்கள்
Board meeting scheduled for January 20, 2026, to discuss Q3 results and dividend.Record date for the potential 2nd interim dividend is set for January 24, 2026.Trading window remains closed from January 1 to January 22, 2026.The meeting will cover both standalone and consolidated financial results for the nine-month period.
👀 கவனிக்க வேண்டியவை
Investors should watch for the dividend amount and Q3 earnings performance on January 20. To be eligible for the dividend, ensure shares are held in the demat account by the record date of January 24.
DCM Ltd Settles ₹8.12 Crore VAT Dispute for ₹1.14 Crore Under Punjab OTS Scheme
DCM Limited has successfully concluded a long-standing VAT litigation with the Punjab Excise and Taxation Department for the period FY 2010-11 to 2013-14. Under the Punjab One Time Settlement Scheme (OTSS) 2025, the company settled a total demand of ₹8.12 crore, which included basic tax, interest, and penalties, for a final payment of ₹1.14 crore. As the company had already deposited ₹99 lakhs during the appeal process, the incremental cash outflow was minimal. This settlement effectively eliminates a significant contingent liability and prevents future interest accruals, cleaning up the company's balance sheet.
முக்கிய அம்சங்கள்
Settled total tax demand of ₹811.67 lakhs (including interest and penalty) for a final amount of ₹113.89 lakhs.The settlement covers four financial years from 2010-11 to 2013-14 regarding Entry Tax credit on High Speed Diesel (HSD).Achieved full waiver of interest and penalties under the Punjab Government's OTSS 2025 notification.Incremental cash outflow was limited as the company had already deposited ₹99 lakhs with the authorities previously.Final settlement order received on December 30, 2025, resulting in the closure of all associated contingent liabilities.
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive development that removes legal uncertainty and financial risk at a fraction of the original demand. The management's decision to utilize the OTS scheme reflects prudent risk mitigation and balance sheet management.
DCM Shriram Industries Reconstitutes Board; Appoints New MD & CEO with Remuneration Hike
DCM Shriram Industries has announced a major board reconstitution following an NCLT-approved Scheme of Arrangement. Mr. Alok Bansidhar Shriram has resigned as Sr. MD & CEO, and Mr. Madhav Bansidhar Shriram has been redesignated as MD & CEO with a basic salary hike from Rs. 5.8 lakh to Rs. 7.5 lakh per month. Additionally, two new executive directors, Mr. Uday Shriram and Mr. Rohan Shriram, have been inducted to lead the restructured entity. The changes are part of a broader corporate reorganization involving the creation of two new resultant companies.
முக்கிய அம்சங்கள்
Resignation of Mr. Alok Bansidhar Shriram (Sr. MD & CEO) and Mrs. Urvashi Tilakdhar (WTD) effective Dec 23, 2025.Mr. Madhav Bansidhar Shriram redesignated as MD & CEO with basic salary increased to Rs. 7.5 lakh per month.MD & CEO commission increased from up to 3% of PBT to up to 5% of PBT effective FY 2025-26.Induction of Mr. Uday Shriram as Dy. Managing Director and Mr. Rohan Shriram as Whole Time Director.Board changes implemented to facilitate the NCLT-approved Scheme of Arrangement involving three distinct corporate entities.
👀 கவனிக்க வேண்டியவை
Investors should track the operational transition as the company implements its Scheme of Arrangement and monitor the performance of the new leadership team. The significant increase in MD remuneration and the induction of next-generation promoters suggest a long-term leadership transition.
DCM Shriram Industries Revises Record Date to Dec 26 for 1:1 Demerger Allotment
DCM Shriram Industries has announced a revision in the record date for its Composite Scheme of Arrangement to December 26, 2025, from the previous date of December 19. Under the scheme, eligible shareholders will receive one equity share each in two new entities, DCM Shriram Fine Chemicals Limited and DCM Shriram International Limited, for every one share held in the parent company. The delay is due to administrative formalities regarding the extinguishment and allotment of shares for a transferor company. The new shares are expected to be listed on the BSE and NSE within 45-60 days after the necessary applications are filed.
முக்கிய அம்சங்கள்
Revised Record Date for the demerger entitlement is now Friday, December 26, 2025.Share entitlement ratio fixed at 1:1 for both DCM Shriram Fine Chemicals and DCM Shriram International.All shares involved in the transaction have a face value of INR 2 per share.Listing of the two new resultant companies is estimated to take 45-60 days post-allotment.The delay was caused by formalities related to the transferor company, Lily Commercial Private Limited.
👀 கவனிக்க வேண்டியவை
Investors must hold DCMSRIND shares until the revised record date of December 26 to qualify for the new shares. Be prepared for a temporary lack of liquidity in the demerged entities for approximately two months until listing is completed.
DCM Shriram Industries Revises Record Date for Demerger to December 26, 2025
DCM Shriram Industries Limited has announced a revision in the record date for its corporate restructuring plan from December 19 to December 26, 2025. This restructuring involves the allotment of shares in two new entities: DCM Shriram Fine Chemicals Limited and DCM Shriram International Limited. The delay is attributed to administrative formalities regarding the extinguishment and allotment of shares involving Lily Commercial Pvt. Limited. Shareholders holding the stock as of the new record date will be eligible for the share allotment in the resultant companies.
முக்கிய அம்சங்கள்
Revised Record Date for the Scheme of Arrangement is now December 26, 2025.The previous record date was set for December 19, 2025.Entitlement includes shares in two new entities: DCM Shriram Fine Chemicals and DCM Shriram International.Delay caused by pending formalities related to the transferor company, Lily Commercial Pvt. Limited.
👀 கவனிக்க வேண்டியவை
Investors interested in receiving shares of the two demerged entities must ensure they hold the stock until the revised record date of December 26, 2025. No immediate action is required other than noting the one-week delay in the process.
DCM: Mr. Arjit Gupta Resigns as Company Secretary & Compliance Officer
DCM Limited announced the resignation of Mr. Arjit Gupta as Company Secretary & Compliance Officer, effective December 12, 2025. Mr. Gupta is leaving to pursue opportunities outside the organization, as stated in his resignation letter dated November 12, 2025. The company has initiated the process to file necessary forms with the Registrar of Companies and inform the stock exchanges. Investors should note this change in key managerial personnel.
முக்கிய அம்சங்கள்
Mr. Arjit Gupta resigned as Company Secretary & Compliance Officer effective December 12, 2025.Resignation letter was dated November 12, 2025.Mr. Gupta's ICSI Membership No. is A30696.
👀 கவனிக்க வேண்டியவை
Investors should monitor upcoming announcements regarding the appointment of a new Company Secretary & Compliance Officer. This change may have implications for corporate governance and compliance procedures.
DCM Shriram and Bayer Crop Science Sign Strategic MoU for Sustainable Agriculture
DCM Shriram Limited has signed a Memorandum of Understanding (MoU) with Bayer Crop Science Limited to jointly explore opportunities in India's agriculture ecosystem. The partnership focuses on agri-inputs, digital advisory, seeds, and specialty plant nutrition, leveraging Bayer's global R&D and DCM Shriram's extensive rural footprint. The collaboration also extends to exploring synergies in the chemicals business and sustainable initiatives like carbon sequestration. This strategic alliance aims to enhance farmer productivity and create long-term value through integrated crop management solutions.
முக்கிய அம்சங்கள்
Strategic MoU signed on December 10, 2025, to advance sustainable and future-ready agriculture.Collaboration covers agri-inputs, digital tools, seeds, specialty plant nutrition, and biologicals.Companies to evaluate joint opportunities in select areas of the chemicals business.Focus on soil health, carbon sequestration, and integrated crop management pilots.Combines Bayer's global expertise with DCM Shriram's deep rural engagement and manufacturing capabilities.
👀 கவனிக்க வேண்டியவை
This partnership with a global leader like Bayer is a significant positive for DCM Shriram's agri-business segment. Investors should monitor for specific product launches or revenue-generating projects resulting from this collaboration over the next few quarters.
DCM Shriram Industries Sets Dec 19 Record Date for 1:1:1 Demerger into Three Entities
DCM Shriram Industries (DCMSR) has announced December 19, 2025, as the record date for its composite scheme of arrangement. Under the scheme, the company is demerging its Chemicals and Rayon businesses into two separate entities: DCM Shriram Fine Chemicals and DCM Shriram International. Eligible shareholders will receive 1 share of each new entity for every 1 share held in DCMSR, effectively splitting the conglomerate into three distinct listed companies focusing on Sugar, Chemicals, and Rayon respectively.
முக்கிய அம்சங்கள்
Record date for share entitlement fixed as Friday, December 19, 2025.Shareholders to receive 1 share of DSFCL and 1 share of DSIL for every 1 share of DCMSR held.Chemicals business demerged into DSFCL and Rayon business demerged into DSIL.DCMSR will retain the Sugar business, including power and alcohol undertakings.Both new entities (DSFCL and DSIL) will be listed on BSE and NSE following the allotment.
👀 கவனிக்க வேண்டியவை
Investors seeking to participate in the value unlocking should ensure they hold shares before the record date of December 19. Be prepared for a significant price adjustment in DCMSR stock on the record date as the value of the demerged businesses is separated.
DCM Shriram Industries: Record Date for Scheme of Arrangement is 19-Dec-2025
DCM Shriram Industries Limited announced a record date of December 19, 2025, for the Composite Scheme of Arrangement. Shareholders will receive one fully paid-up share of ₹2 in each of the two resultant companies, DCM Shriram Fine Chemicals (DSFCL) and DCM Shriram International Limited (DSIL), for every share held in DCM Shriram Industries. The equity shares of each Resultant Companies will be issued to the shareholders of DCM Shriram Industries Limited (DCMSR) in the ratio of 1:1. This follows the NCLT's sanction of the scheme involving Lily Commercial Private Limited, DCM Shriram Fine Chemicals Limited, and DCM Shriram International Limited.
முக்கிய அம்சங்கள்
Record date is 19-Dec-2025 for the Composite Scheme of Arrangement.Shareholders receive one share in each of DSFCL and DSIL for every share in DCM Shriram Industries.Equity Shares of each Resultant Companies will be issued to the shareholders of DCM Shriram Industries Limited (DCMSR) in the ratio of 1:1.Scheme involves Lily Commercial Private Limited, DCM Shriram Fine Chemicals Limited, and DCM Shriram International Limited.
👀 கவனிக்க வேண்டியவை
Shareholders should note the record date of December 19, 2025, to be eligible for the share allocation in DCM Shriram Fine Chemicals and DCM Shriram International. Monitor further announcements regarding the scheme's effectiveness after filing with the Registrar of Companies.
DCM Shriram Industries Appoints Anurag Surana and Sidharth Prasad as Independent Directors
DCM Shriram Industries has appointed Mr. Anurag Surana and Mr. Sidharth Prasad as Independent Directors effective December 10, 2025. Mr. Surana brings over 35 years of experience in the chemical industry, including a 20-year tenure at PI Industries where he served as Executive Director for 14 years. Mr. Prasad adds significant expertise in the sugar and energy sectors, currently serving on the board of L.H. Sugar Factories which operates a 12,500 TCD crushing capacity. These appointments are expected to strengthen the board's strategic oversight in the company's core business segments.
முக்கிய அம்சங்கள்
Appointment of Mr. Anurag Surana and Mr. Sidharth Prasad as Independent Directors effective Dec 10, 2025Mr. Surana has 35+ years of experience in agrochemicals and was an Executive Director at PI Industries for 14 yearsMr. Prasad manages sugar operations with 12,500 TCD crushing and 160 KLPD ethanol production capacityBoth directors confirmed they are not debarred from holding office by SEBI or any other authorityThe appointments aim to enhance board expertise in chemicals, sugar, and strategic growth
👀 கவனிக்க வேண்டியவை
Investors should view these appointments as a positive move to bring in seasoned industry veterans to the board. The addition of a former PI Industries leader is particularly noteworthy for the company's chemical business prospects.
DCM Shriram Industries: Board Appoints Two New Independent Directors
DCM Shriram Industries Limited announced the appointment of Mr. Anurag Surana (DIN:00006665) and Mr. Sidharth Prasad (DIN:00074194) as Independent Directors, effective December 10, 2025. Mr. Surana has over 35 years of experience in the chemical industry and was previously an Executive Director at PI Industries Ltd for 14 years. Mr. Prasad has experience across sugar, hospitality, real estate, and energy sectors and is a Board Member of L.H. Sugar Factories Limited with a crushing capacity of 12,500 tons daily. The board meeting commenced at 12:00 Noon and concluded at 1:00 P.M.
முக்கிய அம்சங்கள்
Mr. Anurag Surana appointed as Independent Director effective 10.12.2025 (DIN:00006665)Mr. Sidharth Prasad appointed as Independent Director effective 10.12.2025 (DIN:00074194)Mr. Surana has over 35 years of experience.Mr. Prasad is a Board Member of L.H. Sugar Factories Limited with a daily crushing capacity of 12,500 tons.
👀 கவனிக்க வேண்டியவை
Investors should monitor the performance and contributions of the new independent directors. No immediate action is required.
DCMNVL: Rajinder Khanna Re-designated as Independent Director
DCM Nouvelle Limited's board meeting on December 05, 2025, approved the re-designation of Mr. Rajinder Khanna from Additional Non-Executive Non-Independent Director to Additional Non-Executive Independent Director. This change is effective from December 05, 2025, subject to shareholder approval. Mr. Khanna has 46 years of experience in the Government of India. He is not debarred from holding the office of Director by any SEBI order.
முக்கிய அம்சங்கள்
Mr. Rajinder Khanna re-designated as Additional Non-Executive Independent Director effective December 05, 2025Mr. Khanna has 46 years of experience in the Government of IndiaBoard Meeting commenced at 03:30 P.M. and concluded at 03:50 P.M.
👀 கவனிக்க வேண்டியவை
Shareholders should review Mr. Khanna's profile and experience as they consider approving his re-designation at the upcoming shareholder meeting. Monitor company announcements for updates on the shareholder vote.
DCM Shriram Industries Receives NCLT Approval for Demerger of Chemical and Rayon Units
DCM Shriram Industries Limited (DCMSRIND) has received the certified true copy of the NCLT order sanctioning its Composite Scheme of Arrangement. The scheme involves the amalgamation of Lily Commercial Private Limited into DCMSRIND, followed by the demerger of its Chemical and Rayon businesses into two separate entities. This restructuring aims to unlock shareholder value by creating focused, independent platforms for the Sugar, Chemical, and Rayon business verticals.
முக்கிய அம்சங்கள்
NCLT New Delhi Bench sanctioned the composite scheme involving one merger and two demergers.Chemical Undertaking will be demerged into DCM Shriram Fine Chemicals Limited (Resultant Company 1).Rayon Undertaking will be demerged into DCM Shriram International Limited (Resultant Company 2).The Sugar business (Residual Undertaking) will remain within the parent entity, DCM Shriram Industries Limited.The scheme becomes effective upon filing the certified order with the Registrar of Companies (ROC), New Delhi.
👀 கவனிக்க வேண்டியவை
Investors should monitor for the announcement of the 'Effective Date' and 'Record Date' to determine eligibility for shares in the demerged entities. This restructuring is a significant value-unlocking event for long-term shareholders.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
